Dong-A boosting R&D spending

Published: 2013-01-15 06:58:00

Updated: 2013-01-15 06:58:00

Top local drug maker Dong-A Pharmaceutical plans to spend more on research and development (R&D) projects in a bid to accelerate development of new original drugs and increase exports.

The company announced Friday it will make a 100 billion won investment in R&D this year, up 18 percent from l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK